• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Complete response of myeloid/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia/myeloid sarcoma to imatinib monotherapy.

作者信息

Ma Rui, Huang Xiao-Jun, Jia Jin-Song, Kong Jun, Qin Ya-Zhen, Jiang Hao

机构信息

Peking University Institute of Hematology, Peking University People's Hospital, Beijing 100044, China.

出版信息

Chin Med J (Engl). 2019 Oct 20;132(20):2498-2500. doi: 10.1097/CM9.0000000000000437.

DOI:10.1097/CM9.0000000000000437
PMID:31567386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6831079/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8d/6831079/469abbede991/cm9-132-2498-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8d/6831079/469abbede991/cm9-132-2498-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6d8d/6831079/469abbede991/cm9-132-2498-g001.jpg

相似文献

1
Complete response of myeloid/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia/myeloid sarcoma to imatinib monotherapy.表现为白血病/髓系肉瘤的伴有血小板衍生生长因子受体α（PDGFRA）重排的髓系/淋系肿瘤对伊马替尼单药治疗的完全缓解
Chin Med J (Engl). 2019 Oct 20;132(20):2498-2500. doi: 10.1097/CM9.0000000000000437.
2
Complete response of myeloid sarcoma with FIP1L1-PDGFRA -associated myeloproliferative neoplasms to imatinib mesylate monotherapy.伊马替尼甲磺酸盐单药治疗 FIP1L1-PDGFRA 相关骨髓增生性肿瘤伴髓系肉瘤的完全缓解。
Acta Haematol. 2012;128(2):83-7. doi: 10.1159/000338217. Epub 2012 Jun 19.
3
Complete response of monoblastic myeloid sarcoma with FIP1L1- PDGFRA rearrangement to imatinib monotherapy.伴有FIP1L1-PDGFRA重排的单核细胞性髓系肉瘤对伊马替尼单药治疗的完全缓解
Br J Haematol. 2014 Jun;165(5):583. doi: 10.1111/bjh.12742. Epub 2014 Jan 24.
4
Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation.携带FIP1L1-PDGFRA突变的嗜酸性粒细胞增多性髓系肿瘤的下一代测序
Am J Hematol. 2016 Mar;91(3):E10-1. doi: 10.1002/ajh.24273. Epub 2016 Jan 11.
5
A case of nonleukemic myeloid sarcoma with FIP1L1-PDGFRA rearrangement: an unusual presentation of a rare disease.伴有 FIP1L1-PDGFRA 重排的非白血病性髓样肉瘤：一种罕见疾病的不常见表现。
Am J Surg Pathol. 2013 Jan;37(1):147-51. doi: 10.1097/PAS.0b013e31826df00b.
6
Imatinib Treatment of Lymphomatoid Papulosis Associated with Myeloproliferative Hypereosinophilic Syndrome Presenting the FIP1L1-PDGFRA Fusion Gene.伊马替尼治疗与呈现FIP1L1-PDGFRA融合基因的骨髓增殖性嗜酸性粒细胞增多综合征相关的淋巴瘤样丘疹病。
Acta Derm Venereol. 2017 Jul 6;97(7):855-857. doi: 10.2340/00015555-2669.
7
Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate.伴显著嗜酸性粒细胞增多和 PDGFRA 重排的髓系肿瘤，用甲磺酸伊马替尼治疗。
Pediatr Blood Cancer. 2010 Oct;55(4):730-2. doi: 10.1002/pbc.22655.
8
Complete and long-lasting cytologic and molecular remission of FIP1L1-PDGFRA-positive acute eosinophil myeloid leukaemia, treated with low-dose imatinib monotherapy.采用低剂量伊马替尼单药治疗FIP1L1-PDGFRA阳性急性嗜酸性粒细胞髓性白血病，实现完全且持久的细胞学和分子学缓解。
Eur J Haematol. 2014 Jun;92(6):541-5. doi: 10.1111/ejh.12272. Epub 2014 Feb 19.
9
Myeloid Neoplasm With Eosinophilia and FIP1L1-PDGFRA Rearrangement Treated With Imatinib Mesylate: A Pediatric Case With Long-term Follow-up.甲磺酸伊马替尼治疗的伴嗜酸性粒细胞增多和FIP1L1-PDGFRA重排的髓系肿瘤：1例长期随访的儿科病例
J Pediatr Hematol Oncol. 2019 May;41(4):334-335. doi: 10.1097/MPH.0000000000001446.
10
Long-term follow-up of treatment with imatinib in eosinophilia-associated myeloid/lymphoid neoplasms with PDGFR rearrangements in blast phase.伊马替尼治疗处于急变期的伴有血小板衍生生长因子受体（PDGFR）重排的嗜酸性粒细胞增多相关髓系/淋系肿瘤的长期随访
Leukemia. 2013 Nov;27(11):2254-6. doi: 10.1038/leu.2013.129. Epub 2013 Apr 25.

引用本文的文献

1
[Intraperitoneal perfusion of gemtuzumab-ozogamicin combined with allogeneic hematopoietic stem cell transplantation in intestinal solitary myeloid sarcoma: a case report and literature review].[吉妥珠单抗-奥唑米星腹腔灌注联合异基因造血干细胞移植治疗肠道孤立性髓系肉瘤：1例报告并文献复习]
Zhonghua Xue Ye Xue Za Zhi. 2020 Aug 14;41(8):683-685. doi: 10.3760/cma.j.issn.0253-2727.2020.08.013.

本文引用的文献

1
A neoplasm with FIP1L1-PDGFRA fusion presenting as pediatric T-cell lymphoblastic leukemia/lymphoma without eosinophilia.一种具有FIP1L1-PDGFRA融合基因的肿瘤，表现为无嗜酸性粒细胞增多的儿童T细胞淋巴母细胞白血病/淋巴瘤。
Cancer Genet. 2017 Oct;216-217:91-99. doi: 10.1016/j.cancergen.2017.07.007. Epub 2017 Aug 3.
2
Complete and long-lasting cytologic and molecular remission of FIP1L1-PDGFRA-positive acute eosinophil myeloid leukaemia, treated with low-dose imatinib monotherapy.采用低剂量伊马替尼单药治疗FIP1L1-PDGFRA阳性急性嗜酸性粒细胞髓性白血病，实现完全且持久的细胞学和分子学缓解。
Eur J Haematol. 2014 Jun;92(6):541-5. doi: 10.1111/ejh.12272. Epub 2014 Feb 19.
3
Complete response of monoblastic myeloid sarcoma with FIP1L1- PDGFRA rearrangement to imatinib monotherapy.
伴有FIP1L1-PDGFRA重排的单核细胞性髓系肉瘤对伊马替尼单药治疗的完全缓解
Br J Haematol. 2014 Jun;165(5):583. doi: 10.1111/bjh.12742. Epub 2014 Jan 24.
4
Five years since the discovery of FIP1L1-PDGFRA: what we have learned about the fusion and other molecularly defined eosinophilias.发现FIP1L1-PDGFRA五年以来：我们对该融合基因及其他分子定义的嗜酸性粒细胞增多症的了解
Leukemia. 2008 Nov;22(11):1999-2010. doi: 10.1038/leu.2008.287. Epub 2008 Oct 9.